November 2019 - Page 2 of 6

FridayNov 22, 2019 9:00 am

NY Activists Vow to Improve Stalled CBD and Hemp Bill

The 2018 Hemp Farming Act was a godsend for the hemp industry. The legislation classified cannabis with less than 0.3 percent THC as hemp and removed it from its list of controlled substances. Dubbed by some as a catalyst for explosive growth, the bill gave farmers in all 50 states leeway to grow the versatile cash crop under regulation. Six months later in June 2019, the New York Assembly passed the state's own Hemp Extract Bill. The bill would have allowed licensed retailers to add up to 20mg of CBD per twelve ounces beverage. However, several months later, the bill…

ThursdayNov 21, 2019 4:00 pm

Mother Shares Story of Son’s Miraculous Cure After Taking CBD

Cannabidiol is without a doubt the breakout star among medicines this decade, if not the century. The cannabis extract is a darling of the medicine, sports, and the health and wellness communities, with potent and versatile medicinal properties that make it effective against a wide range of diseases. A lot of people use it for pain and anxiety relief, but anecdotally, CBD has worked against high blood pressure, improved sleep and reduced seizures in people with epilepsy. In June 2018, the FDA approved a CBD-based medication to help manage seizures in rare forms of childhood epilepsy. Recently the UK National…

ThursdayNov 21, 2019 12:55 pm

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Eyes Opportunity to Provide Biosynthetic Cannabinoids in Market with Explosive Potential

Willow’s plan to provide biosynthetic cannabinoid has potential to disrupt the cannabis-industry supply chain Biosynthetically derived cannabinoids offer unique advantages related to reliability, scalability, quality and cost Key collaboration allows company to capitalize on enormous market opportunity Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF), an emerging biotechnology company focused on the biosynthetic production of cannabinoids, believes that the cannabis industry presents an exciting opportunity for the well-positioned company. As the market anticipates the legalization of cannabis-derivative products in Canada, and the CBD legal landscape continues to change rapidly in the United States and around the world, cannabinoids are appearing as…

ThursdayNov 21, 2019 11:36 am

ChineseInvestors.com Inc. (CIIX) CEO Describes Tremendous Opportunity in CBD-Cosmetics to China’s Market of 1.4 Billion Consumers

CIIX anticipates launch of hemp-infused wrinkle cream in China Through subsidiary CBD Biotech, CIIX will focus hemp and CBD products on the blooming Chinese market The company noted impressive sales, revenue growth for Q1 2020, greatly due to success of CBD Biotech ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang noted the enormous potential for cosmetics infused with industrial hemp in a RedChip Money Report interview. This sentiment was echoed in his letter to shareholders, where he noted that CBD-infused cosmetics will the company and its subsidiary, CBD Biotech, to a Chinese market of 1.4 billion people. CIIX plans to launch…

ThursdayNov 21, 2019 9:00 am

CBD Christmas Pudding Now Available in the UK

Very few products can claim to have achieved the kind of fame cannabidiol has in the short time it has been mainstream. The US CBD market alone was estimated to be $1.3 billion in 2018, and it is expected to hit $23 billion by 2025. The compound is a potent and versatile medicine, and it has been found effective against a range of medical conditions from anxiety and high blood pressure to chronic pain. UK lifestyle retailer Firebox is looking to cash in on the CBD craze through a completely novel and unique idea; CBD Christmas pudding. The £9.99 ($12.9)…

WednesdayNov 20, 2019 4:00 pm

Company Teams Up With Florida State University to Study Painkilling Effects of CBD

CBD, or cannabidiol, as the nerds call it is a hemp extract that has completely taken the world by storm. The compound is said to be effective against a variety of medical conditions, ranging from insomnia to chronic pain and high blood pressure. In June 2018, the FDA approved a CBD-based drug to treat epilepsy-related seizures in children. 14% of all Americans use CBD, and roughly 40% of these users do it for pain relief. Arguably, there has been a lot of interest in cannabidiol's anti-inflammatory properties, especially as an alternative to opiates. A leading hemp research company is looking…

WednesdayNov 20, 2019 1:46 pm

MCTC Holdings Inc. (MCTC) Advances Cannabinoid Delivery Research Efforts, Files Fourth High-Tech Patent

Most significant patent filed is also the most comprehensive, covering broad areas of cannabinoid polymeric nanoparticles and fibers Company is committed to continuing research program and expand its intellectual property portfolio over the coming months MCTC participating in multiple growing verticals within global cannabis industry through acquisitions, strategic partnerships, and intellectual property MCTC Holdings Inc. (OTC: MCTC), a cannabinoid science innovator focused on high-growth and high-margins sub-sectors of the cannabis and hemp industry, filed its fourth cannabinoid delivery technology patent. The patent broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially…

WednesdayNov 20, 2019 11:55 am

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Appointment of Ecommerce Exec to Board of Directors

Former Head of Digital Commerce at HSN, Jill Braff brings a wealth of experience in marketing, e-commerce to her new role CEO believes PLUS online CBD business will be transformative for the company Braff deems PLUS one of most promising companies in a high-growth industry Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis-branded product company with the two best-selling cannabis products in California, recently announced the appointment of ecommerce senior executive Jill Braff to the company’s board of directors (http://cnw.fm/Hr3iT). The move is aimed at further strengthening the company’s already impressive digital sales and marketing expertise. “We couldn’t be…

WednesdayNov 20, 2019 9:00 am

CBD Helps Connecticut Chiropractor With Lyme Disease To Quit OTC Medications

If you haven't been living under a rock for the past few years, you have undoubtedly heard about cannabidiol (CBD). The cannabis extract has been impressing consumers with its medicinal properties, and it is set to be one of, if not the most, versatile medicines of the century. The compound has been found effective against a host of conditions ranging from chronic pain to seizures in rare childhood epilepsies. At least 40% of the people who use CBD do so for pain relief. Gene Gresh, a compounding pharmacist, says, "Anecdotally, we see amazing pain relief qualities when it's used topically.…

TuesdayNov 19, 2019 4:00 pm

Industry Upset as Germany Classifies CBD as a Novel Food

The hemp sector in Germany has been left in a bind after the country's federal government recently confirmed that cannabidiol (CBD) is to be classified as a novel food. Entities interested in selling CBD products will have to apply for marketing authorization before sending their products into the market, a tedious and expensive process. A novel food is a type of food that doesn't have much history of consumption or is produced through previously unused methods. European Union (EU) regulations state that “any food that was not consumed significantly before March 1997 is considered a novel food. The category covers…